Skip to content

Effect of Satavar (Asparagus racemosus) in patients having post-menopausal symptoms.

Clinical Efficacy of Satavar (Asparagus racemosus) in Post-Menopausal Syndrome (Mutlazima Sinne Yaas) - A randomized placebo control single blind study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084079
Enrollment
100
Registered
2025-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

Intervention1: POWDERED SATAVAR: 5gm POWDER OF SATAVAR TWICE DAILY FOR 3 MONTHS. THIS DRUG HAVE PHYTOESTROGENIC PROPERTIES ALONG WITH MUQAWWI-E-QALB (CARDIAC TONIC), MUHALLIL-E-WARM (ANTI-INFLAMMATORY

Sponsors

SUMAIYYA KHANAM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH HISTORY OF AMENORRHOEA FOR 1 YEAR ASSOCIATED WITH HOT FLASHES ALONG WITH MORE THAN OR EQUAL TO 3 SYMPTOMS THAT ARE MENTIONED IN THE GREENE CLIMACTERIC SCALE

Exclusion criteria

Exclusion criteria: PATIENT HAVING AMENORRHEA DUE TO OTHER PATHOLOGY,OR SUFFERING FROM HTN, TB, CANCER, DM, THYROID DISORDER, STI, LIVER AND KIDNEY DISEASE, ESTABLISHED CASES OF ANY MAJOR PSYCHIATRIC DISORDER SUCH AS SCHIZOPHRENIA AND MENTAL RETARDATION, PATIENT ON HORMONE REPLACEMENT THERAPY WITHIN 60 DAYS OF STUDY PERIOD OR POST-MENOPAUSAL BLEEDING.

Design outcomes

Primary

MeasureTime frame
RELIEF IN HOT FLASHES AND OTHER ASSOCIATED SYMPTOMS OF POST MENOPAUSAL SYNDROMETimepoint: SYMPTOMS WILL BE ASSESSED AT THE INITIATION OF THE STUDY AND MONTHLY FOR 3 MONTHS

Secondary

MeasureTime frame
IMPROVEMENT IN GREENE CLIMACTERIC SCALE IMPROVEMENT IN QUALITY OF LIFE (QOL) QUESTIONNAIRE IMPROVEMENT IN MENOPAUSE SPECIFIC TREATMENT SATISFACTION QUESTIONNAIRE (MS-TSQ) CHANGES IN SERUM ESTRADIOL LEVELTimepoint: GREEN CLIMACTERIC SCALE,QOL QUESTIONNAIRE, MS-TSQ WILL BE ASSESSED AT THE INITIATION OF THE STUDY AND MONTHLY FOR 3 MONTHS AND SERUM ESTRADIOL LEVEL WILL BE DONE BEFORE AND AFTER TREAMENT

Countries

India

Contacts

Public ContactPROF SYEDA AAMENA NAAZ

ALIGARH MUSLIM UNIVERSITY

syedanaaz@yahoo.com9412672189

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026